HBV-IN-16

Modify Date: 2025-08-28 00:33:10

HBV-IN-16 Structure
HBV-IN-16 structure
Common Name HBV-IN-16
CAS Number 2355225-38-4 Molecular Weight 397.85
Density N/A Boiling Point N/A
Molecular Formula C22H20ClNO4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HBV-IN-16


HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1].

 Names

Name HBV-IN-16

 HBV-IN-16 Biological Activity

Description HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1].
Related Catalog
References

[1]. Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1.

 Chemical & Physical Properties

Molecular Formula C22H20ClNO4
Molecular Weight 397.85
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.